Zinc binding to amyloid-β: Isothermal titration calorimetry and Zn competition experiments with Zn sensors

Biochemistry

Volumn 46, Issue 47, 2007, Pages 13658-13666

  Talmard, Christine ^a   Bouzan, Anaïs ^a   Faller, Peter ^a  

^a LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALORIMETRY; CHELATION; CHEMICAL SENSORS; NEURONS; STARCH; TITRATION; TOXIC MATERIALS;

AGGREGATION PROPERTIES; ISOTHERMAL TITRATION; MICROMOLAR RANGE; PLAQUES;

ZINC;

AMYLOID BETA PROTEIN[25-35]; HISTIDINE; ZINC;

ARTICLE; CHELATION; ISOTHERMAL TITRATION CALORIMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BINDING SITES; CALORIMETRY; KINETICS; PEPTIDE FRAGMENTS; TEMPERATURE; THERMODYNAMICS; ZINC;

EID: 36749044742     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701355j     Document Type: Article

References (67)

1. Suh, Y. H., and Checler, F. (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease, Pharmacol. Rev. 54, 469-525.
2. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297, 353-356.
3. Klein, W. L., Stine, W. B., Jr., and Teplow, D. B. (2004) Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease, Neurobiol. Aging 25, 569-580.
4. Multhaup, G., and Masters, C. L. (1999) Metal binding and radical generation of proteins in human neurological diseases and aging, Met. Ions Biol. Syst. 36, 365-387.
5. Bush, A. I., Pettingell, W. H., Multhaup, G., d Paradis, M., Vonsattel, J. P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc, Science 265, 1464-1467.
6. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev. 81, 741-766.
7. Bush, A. I. (2003) The metallobiology of Alzheimer's disease, Trends Neurosci. 26, 207-214.
8. Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., and Bush, A. I. (1999) Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion, J. Biol. Chem. 274, 23223-23228.
9. Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K., and Masters, C. L. (1993) A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease, J. Biol. Chem. 268, 16109-16112.
10. Ciuculescu, E. D., Mekmouche, Y., and Faller, P. (2005) Metal-binding properties of the peptide APP170-188: a model of the ZnII-binding site of amyloid precursor protein (APP), Chemistry 11, 903-909.
11. Lee, J. Y., Cole, T. B., Palmiter, R. D., Suh, S. W., and Koh, J. Y. (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 99, 7705-7710.
12. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., and Bush, A. I. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron 30, 665-676.
13. Lee, J. Y., Friedman, J. E., Angel, I., Kozak, A., and Koh, J. Y. (2004) The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice, Neurobiol. Aging 25, 1315-1321.
14. Adlard, P. A., and Bush, A. I. (2006) Metals and Alzheimer's disease, J. Alzheimer's Dis. 10, 145-163.
15. Boldron, C., Van der Auwera, I., Deraeve, C., Gornitzka, H., Wera, S., Pitie, M., Van Leuven, F., and Meunier, B. (2005) Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases, ChemBioChem 6, 1976-1980.
16. Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., and Maggio, J. E. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide, J. Neurochem. 61, 1171-1174.
17. Bush, A. I., Pettingell, W. H., Jr., Paradis, M. D., and Tanzi, R. E. (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc, J. Biol. Chem. 269, 12152-12158.
18. Talmard, C., Guilloreau, L., Coppel, Y., Mazarguil, H., and Faller, P. (2007) Amyloid-beta peptide forms monomeric complexes with Cu(II) and Zn(II) prior to aggregation, ChemBioChem 8, 163-165.
19. Yang, D. S., McLaurin, J., Qin, K., Westaway, D., and Fraser, P. E. (2000) Examining the zinc binding site of the amyloid-beta peptide, Eur. J. Biochem. 267, 6692-6698.
20. Raman, B., Ban, T., Yamaguchi, K., Sakai, M., Kawai, T., Naiki, H., and Goto, Y. (2005) Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide, J. Biol. Chem. 280, 16157-16162.
21. Klug, G. M., Losic, D., Subasinghe, S. S., Aguilar, M. I., Martin, L. L., and Small, D. H. (2003) Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral Ph, Eur. J. Biochem. 270, 4282-4293.
22. Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., and Takashima, A. (2001) New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity, J. Biol. Chem. 276, 32293-32299.
23. House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., and Exley, C. (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J. Alzheimer's Dis. 6, 291-301.
24. Liu, S. T., Howlett, G., and Barrow, C. J. (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease, Biochemistry 38, 9373-9378.
25. Miura, T., Suzuki, K., Kohata, N., and Takeuchi, H. (2000) Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes, Biochemistry 39, 7024-7031.
26. Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., and Barnham, K. J. (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J. Biol. Chem. 276, 20466-20473.
27. Kozin, S. A., Zirah, S., Rebuffat, S., Hoa, G. H., and Debey, P. (2001) Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex, Biochem. Biophys. Res. Commun. 285, 959-964.
28. Mekmouche, Y., Coppel, Y., Hochgrafe, K., Guilloreau, L., Talmard, C., Mazarguil, H., and Faller, P. (2005) Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease, ChemBioChem 6, 1663-1671.
29. Syme, C. D., and Viles, J. H. (2006) Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease, Biochim. Biophys. Acta 1764, 246-256.
30. Zirah, S., Rebuffat, S., Kozin, S. A., Debey, P., Fournier, F., Lesage, D., and Tabet, J.-C. (2003) Zinc binding properties of the amyloid fragment Ab(1-16) studied by electrospray-ionization mass spectrometry, Int. J. Mass Spectrom. 228, 999-1016.
31. Zirah, S., Kozin, S. A., Mazur, A. K., Blond, A., Cheminant, M., Segalas-Milazzo, I., Debey, P., and Rebuffat, S. (2006) Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging, J. Biol. Chem. 281, 2151-2161.
32. Stellato, F., Menestrina, G., Serra, M. D., Potrich, C., Tomazzolli, R., Meyer-Klaucke, W., and Morante, S. (2006) Metal binding in amyloid beta-peptides shows intra- and inter-peptide coordination modes, Eur. Biophys. J. 35, 340-351.
33. Hou, L., and Zagorski, M. G. (2006) NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease, J. Am. Chem. Soc. 128, 9260-9261.
34. Danielsson, J., Pierattelli, R., Banci, L., and Graslund, A. (2007) High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide, FEBS J. 274, 46-59.
35. Clements, A., Allsop, D., Walsh, D. M., and Williams, C. H. (1996) Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease, J. Neurochem. 66, 740-747.
36. Ricchelli, F., Drago, D., Filippi, B., Tognon, G., and Zatta, P. (2005) Aluminum-triggered structural modifications and aggregation of beta-amyloids, Cell. Mol. Life Sci. 62, 1724-1733.
37. Garzon-Rodriguez, W., Yatsimirsky, A. K., and Glabe, C. G. (1999) Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence, Bioorg. Med. Chem. Lett 9, 2243-2248.
38. Hou, L., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. J., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Przybyla, A. B., and Zagorski, M. G. (2004) Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation, J. Am. Chem. Soc. 126, 1992-2005.
39. Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., Condron, M. M., Selkoe, D. J., Lansbury, P. T., Jr., Fink, A. L., and Teplow, D. B. (2000) An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments, Amyloid 7, 166-178.
40. Pierce, M. M., Raman, C. S., and Nall, B. T. (1999) Isothermal titration calorimetry of protein-protein interactions, Methods 19, 213-221.
41. Shaw, C. F., Laib, J. E., Sevas, M. M., and Petering, D. H. (1990), Inorg. Chem. 29, 403-408.
42. Lukowiak, B., Vandewalle, B., Riachy, R., Kerr-Conte, J., Gmyr, V., Belaich, S., Lefebvre, J., and Pattou, F. (2001) Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe, J. Histochem. Cytochem. 49, 519-528.
43. Jiang, P., and Gui, Z. (2004) Florescent detection of zinc in biological systems: recent develpoment on the design of chemosensors and biosensors, Coord. Chem. Rev. 248, 205-229.
44. Fahrni, C. J., and O'Halloran. (1999) Aqueous coordination chemistry of quinoline-based fluorescence probes for the biological chemistry of zinc, J. Am. Chem. Soc. 121, 11448-11458.
45. Nilsson, M. R. (2004) Techniques to study amyloid fibril formation in vitro, Methods 34, 151-160.
46. Ababou, A., and Ladbury, J. E. (2007) Survey of the year 2005: literature on applications of isothermal titration calorimetry, J. Mol. Recognit. 20, 4-14.
47. Privalov, P. L., and Dragan, A. I. (2007) Microcalorimetry of biological macromolecules, Biophys. Chem. 126, 16-24.
48. Ladbury, J. E. (2004) Application of isothermal titration calorimetry in the biological sciences: things are heating up!, Biotechniques 37, 885-887.
49. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (2000) Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42, J. Neurochem. 75, 1219-1233.
50. Zhang, Y., and Wilcox, D. E. (2002) Thermodynamic and spectroscopic study of Cu(II) and Ni(II) binding to bovine serum albumin, J. Biol. Inorg. Chem. 7, 327-337.
51. Blasie, C. A., and Berg, J. M. (2002) Structure-based thermodynamic analysis of a coupled metal binding-protein folding reaction involving a zinc finger peptide, Biochemistry 41, 15068-15073.
52. Blasie, C. A., and Berg, J. M. (2003) Kinetics and thermodynamics of copper(II) binding to apoazurin, J. Am. Chem. Soc. 125, 6866-6867.
53. Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., and Faller, P. (2006) Structural and thermodynamical properties of CuII amyloid-beta 16/28 complexes associated with Alzheimer's disease, J. Biol. Inorg. Chem. 11, 1024-1038.
54. Zhang, Y., Akilesh, S., and Wilcox, D. E. (2000) Isothermal titration calorimetry measurements of Ni(II) and Cu(II) binding to His, GlyGlyHis, HisGlyHis, and bovine serum albumin: a critical evaluation, Inorg. Chem. 39, 3057-3064.
55. Bradshaw, J. M., and Waksman, G. (1998) Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide, Biochemistry 37, 15400-15407.
56. Huang, M., Krepkiy, D., Hu, W., and Petering, D. H. (2004) Zn-, Cd-, and Pb-transcription factor IIIA: properties, DNA binding, and comparison with TFIIIA-finger 3 metal complexes, J. Inorg. Biochem. 98, 775-785.
57. Armas, A., Sonois, V., Mothes, E., Mazarguil, H., and Faller, P. (2006) Zinc(II) binds to the neuroprotective peptide humanin, J. Inorg. Biochem. 100, 1672-1678.
58. Thompson, R. B., Peterson, D., Mahoney, W., Cramer, M., Maliwal, B. P., Suh, S. W., Frederickson, C., Fierke, C., and Herman, P. (2002) Fluorescent zinc indicators for neurobiology, J. Neurosci. Methods 118, 63-75.
59. Wetzel, R. (2006) Kinetics and thermodynamics of amyloid fibril assembly, Acc. Chem. Res. 39, 671-679.
60. Sengupta, P., Garai, K., Sahoo, B., Shi, Y., Callaway, D. J., and Maiti, S. (2003) The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations, Biochemistry 42, 10506-10513.
61. Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., Kowall, N. W., Rogers, J. T., and Huang, X. (2004) Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis, Exp. Gerontol. 39, 1641-1649.
62. Ferrada, E., Arancibia, V., Loeb, B., Norambuena, E., Olea-Azar, C., and Huidobro-Toro, J. P. (2007) Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy, Neurotoxicology 28, 445-449.
63. Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., and Zatta, P. (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes, Inorg. Chem. 43, 3795-3797.
64. Blasie, C. A., and Berg, J. M. (2004) Entropy-enthalpy compensation in ionic interactions probed in a zinc finger peptide, Biochemistry 43, 10600-10604.
65. Krezel, A., and Maret, W. (2006) Zinc-buffering capacity of a eukaryotic cell at physiological pZn, J. Biol. Inorg. Chem. 11, 1049-1062.
66. Walkup, G. K., and Imperiali, B. (1997) Fluorescent chemosensors for divalent zinc based on zinc finger domains. Enhanced oxidative stability, metal binding affinity, and structural and functional characterization, J. Am. Chem. Soc. 119, 3443-3450.
67. Kowalik-Jankowska, T., Ruta, M., Wisniewska, K., and Lankiewicz, L. (2003) Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study, J. Inorg. Biochem. 95, 270-282.